Core E: Cell sorting, CyTOF and RNA-Seq
Core E: Cell sorting, CyTOF and RNA-Seq
批准号:
10188604
负责人:
Klaus F. Ley
金额:
$54.45万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-01 至 2022-05-31
关键词:
AliquotAllelesAntibodiesAntigen-Presenting CellsAntigensArterial Fatty StreakArteriesAtherosclerosisB-LymphocytesBLR1 geneBioinformaticsBiologicalBone MarrowCD4 Positive T LymphocytesCXCR4 geneCaliforniaCell CommunicationCell SeparationCell surfaceCellsCytometryDNADataData AnalysesDimensionsEnsureFlow CytometryFreezingGenesGenomeGenomicsGreater sac of peritoneumHLA AntigensHandHarvestHumanImmuneIn VitroIndividualInstitutesLanthanoid Series ElementsLeukocytesLibrariesLiquid substanceMapsMemoryMethodsModernizationMonoclonal AntibodiesMusNational Heart, Lung, and Blood InstituteNitrogenNucleotidesPathway AnalysisPatientsPerformancePeripheral Blood Mononuclear CellPeritonealPhenotypePlasmaPopulationPreparationPrincipal Component AnalysisProteinsQuality ControlRNARare Earth MetalsRunningSamplingShippingShipsSpleenT-LymphocyteTechnologyTimeTissuesTrans-Omics for Precision MedicineTubeUniversitiesVirginiaantibody conjugatebasecell typedata qualitydesigndifferential expressiondimensional analysisexperienceexperimental studygenome-widehigh dimensionalityhuman RNA sequencinghuman datahuman leukocyte antigen testingin vivoinstrumentmacrophagemass spectrometermonocytenovelpreservationterminally differentiated effector memory (TEM) T cellstooltranscription factortranscriptometranscriptome sequencingtrizolvapor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core E description
Core E has four functions, serving all 4 projects. First, human and mouse T cells, B cells and monocytes will be
sorted from peripheral blood mononuclear cells (PBMCs) and sorted into trizol, RNA extracted, quality controls
(bioanalyzer, Agilent TapeStation) performed, libraries prepared and RNA-Seq done to obtain ~50-70 million
Illumina reads per sample. Preliminary data show excellent sequencing depth and data quality even in long-
term frozen PBMCs. Mouse and human samples are focused on monocyte subsets for project 1, treated
human and sorted mouse macrophages for project 2, B1 cells from peritoneal cavity, spleen and bone marrow
in wild-type, Cxcr4-/- and Cxcr5-/- mice for project 3, and dextramerhigh, dextramerlow, dextramernegative effector
memory (TEM) cells and naïve CD4 T cells for project 4. Second, 36 to 42-parameter mass cytometry (CyTOF)
followed by high-dimensional analysis (SPADE, viSNE) will be used for unsupervised clustering. We have
already acquired or conjugated, titrated and validated more than 100 monoclonal antibodies, developed one
human panel that will serve all projects and four human panels that serve each project individually. We will use
about 1 million cells from each tube for this, and the remaining about 7 million cells will be used for RNA-Seq.
We also will run CyTOF on mouse. CyTOF identifies the known cell types and likely will suggest new, unknown
cell types (new subsets of monocytes, B cells, T cells). Third, sorted T cells and antigen presenting cells
(APCs) will be distributed to project 4 and sorted monocytes to project 1 for functional experiments in vivo and
in vitro as detailed in the projects. Finally, core E will also provide basic bioinformatics support. This includes
post-sequencing quality controls for RNA-Seq, mapping reads, differential expression (DE), heat maps, Venn
diagrams and principal component analysis (PCA).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of kindlin-3-dependent integrin activation
-
批准号:10676897
-
项目类别:
-
资助金额:$54.92万
-
财政年份:2020
-
负责人:Klaus F. Ley
-
依托单位:
Mechanism of kindlin-3-dependent integrin activation
-
批准号:10229369
-
项目类别:
-
资助金额:$54.93万
-
财政年份:2020
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10112954
-
项目类别:
-
资助金额:$90.72万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10369710
-
项目类别:
-
资助金额:$58.9万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:9895858
-
项目类别:
-
资助金额:$90.7万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10623034
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Vascular macrophages and T cells in atherosclerosis
-
批准号:10565907
-
项目类别:
-
资助金额:$76.97万
-
财政年份:2019
-
负责人:Klaus F. Ley
-
依托单位:
Core B: Single Cell Protein and RNA Sequencing Core
-
批准号:10334092
-
项目类别:
-
资助金额:$5.35万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Super-resolution confocal microscope
-
批准号:9274885
-
项目类别:
-
资助金额:$56.63万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Project 4: APOB-specific CD4 and CD8 T cells exacerbate atherosclerosis
-
批准号:10334097
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
ApoB-specific CD4 T cells in mouse and human atherosclerosis
-
批准号:10188608
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2017
-
负责人:Klaus F. Ley
-
依托单位:
Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis
-
批准号:8819012
-
项目类别:
-
资助金额:$45.55万
-
财政年份:2014
-
负责人:Klaus F. Ley
-
依托单位:
Vaccination with MHC-II restricted ApoB100 peptides to prevent atherosclerosis
-
批准号:8966694
-
项目类别:
-
资助金额:$43.63万
-
财政年份:2014
-
负责人:Klaus F. Ley
-
依托单位:
VASCULATA 2013: Vascular Immunology
-
批准号:8597858
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2013
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8675936
-
项目类别:
-
资助金额:$42.48万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions in atherosclerosis
-
批准号:9311933
-
项目类别:
-
资助金额:$45.0万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8346057
-
项目类别:
-
资助金额:$56.61万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:8499418
-
项目类别:
-
资助金额:$43.3万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Myeloid cell interactions with T cells in atherosclerosis
-
批准号:9065736
-
项目类别:
-
资助金额:$43.35万
-
财政年份:2012
-
负责人:Klaus F. Ley
-
依托单位:
Cell Phenotyping Core
-
批准号:8703257
-
项目类别:
-
资助金额:$10.93万
-
财政年份:2008
-
负责人:Klaus F. Ley
-
依托单位:
海外基金